Koninklijke Philips (PHG) Preferred Stock Liabilities (2011 - 2024)
Koninklijke Philips (PHG) recorded quarterly Preferred Stock Liabilities of $7.1 billion in Q4 2024, little changed quarter-over-quarter from $7.1 billion in Q2 2024, and up 13.41% on a YoY basis from $6.3 billion in Q1 2024.
Koninklijke Philips (PHG) Preferred Stock Liabilities (2011 - 2024) Analysis & Trends
Koninklijke Philips' Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $7.1 billion for Q4 2024.
- In Q4 2024, Preferred Stock Liabilities rose 13.41% year-over-year to $7.1 billion; the TTM figure through Dec 2024 stood at $7.1 billion (up 13.41% YoY), while the FY2024 annual figure was $7.1 billion, up 13.41% from the prior year.
- Preferred Stock Liabilities was $7.1 billion for Q4 2024 at Koninklijke Philips, roughly flat from $7.1 billion in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $7.1 billion in Q4 2024 to a low of $5.1 billion in Q4 2022.
- Historically, Preferred Stock Liabilities has averaged $6.2 billion across 4 years, with a median of $6.3 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Preferred Stock Liabilities declined 3.54% in 2022, then grew 22.29% in 2023.
- A 4-year view of Preferred Stock Liabilities shows it stood at $5.3 billion in 2021, then retreated by 3.54% to $5.1 billion in 2022, then increased by 22.29% to $6.3 billion in 2023, then advanced by 13.41% to $7.1 billion in 2024.
- The last three Preferred Stock Liabilities figures came in at $7.1 billion (Q4 2024), $7.1 billion (Q2 2024), and $6.3 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.11 Bn |
| Jun 30, 2024 | 7.10 Bn |
| Dec 31, 2023 | 6.27 Bn |
| Jun 30, 2023 | 6.29 Bn |
| Dec 31, 2022 | 5.13 Bn |
| Dec 31, 2021 | 5.31 Bn |
| Dec 31, 2011 | 1.10 Bn |